ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,385,070, issued on Aug. 12, was assigned to Seattle Children's Hospital (Seattle) and Fred Hutchinson Cancer Center (Seattle).
"Homology directed repair compositions for the treatment of hemoglobinopathies" was invented by Andrew Scharenberg (Seattle), Kyle Jacoby (Seattle), Hans-Peter Kiem (Seattle), David J. Rawlings (Seattle), Christopher Lux (Bremerton, Wash.), Sowmya Pattabhi (Bellevue, Wash.) and Olivier M. Humbert (Seattle).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides improved compositions for the homology directed repair of the human globin locus for the prevention, treatment, or amelioration of at least one symp...